Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
- PMID: 28011898
- DOI: 10.1042/CS20160009
Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
Abstract
Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a key role in the central nervous system, promoting synaptic plasticity, neurogenesis and neuroprotection. The BDNF gene structure is very complex and consists of multiple 5'-non-coding exons, which give rise to differently spliced transcripts, and one coding exon at the 3'-end. These multiple transcripts, together with the complex transcriptional regulatory machinery, lead to a complex and fine regulation of BDNF expression that can be tissue and stimulus specific. BDNF effects are mainly mediated by the high-affinity, tropomyosin-related, kinase B receptor and involve the activation of several downstream cascades, including the mitogen-activated protein kinase, phospholipase C-γ and phosphoinositide-3-kinase pathways. BDNF exerts a wide range of effects on neuronal function, including the modulation of activity-dependent synaptic plasticity and neurogenesis. Importantly, alterations in BDNF expression and function are involved in different brain disorders and represent a major downstream mechanism for stress response, which has important implications in psychiatric diseases, such as major depressive disorders and schizophrenia. In the present review, we have summarized the main features of BDNF in relation to neuronal plasticity, stress response and pathological conditions, and discussed the role of BDNF as a possible target for pharmacological and non-pharmacological treatments in the context of psychiatric illnesses.
Keywords: BDNF; neurogenesis; pharmacological treatment; psychiatric diseases; synaptic plasticity.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.
Similar articles
-
BDNF-induced local protein synthesis and synaptic plasticity.Neuropharmacology. 2014 Jan;76 Pt C:639-56. doi: 10.1016/j.neuropharm.2013.04.005. Epub 2013 Apr 16. Neuropharmacology. 2014. PMID: 23602987 Review.
-
Actions of Brain-Derived Neurotrophin Factor in the Neurogenesis and Neuronal Function, and Its Involvement in the Pathophysiology of Brain Diseases.Int J Mol Sci. 2018 Nov 19;19(11):3650. doi: 10.3390/ijms19113650. Int J Mol Sci. 2018. PMID: 30463271 Free PMC article. Review.
-
Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinson's and Alzheimer's Diseases.Curr Gene Ther. 2018;18(1):45-63. doi: 10.2174/1566523218666180302163029. Curr Gene Ther. 2018. PMID: 29512462 Review.
-
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.Neurobiol Dis. 2015 May;77:220-7. doi: 10.1016/j.nbd.2015.03.011. Epub 2015 Mar 18. Neurobiol Dis. 2015. PMID: 25796564
-
Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: From genes to phenotype.Restor Neurol Neurosci. 2004;22(2):121-30. Restor Neurol Neurosci. 2004. PMID: 15272146 Review.
Cited by
-
Magnoflorine-Loaded Chitosan Collagen Nanocapsules Ameliorate Cognitive Deficit in Scopolamine-Induced Alzheimer's Disease-like Conditions in a Rat Model by Downregulating IL-1β, IL-6, TNF-α, and Oxidative Stress and Upregulating Brain-Derived Neurotrophic Factor and DCX Expressions.ACS Omega. 2023 Jan 3;8(2):2227-2236. doi: 10.1021/acsomega.2c06467. eCollection 2023 Jan 17. ACS Omega. 2023. PMID: 36687096 Free PMC article.
-
Behavioral phenotyping of a rat model of the BDNF Val66Met polymorphism reveals selective impairment of fear memory.Transl Psychiatry. 2022 Mar 7;12(1):93. doi: 10.1038/s41398-022-01858-5. Transl Psychiatry. 2022. PMID: 35256586 Free PMC article.
-
Editorial: Metabolic Mediators and Synapses: Linking Body Periphery to Neural Plasticity.Front Cell Neurosci. 2019 Aug 27;13:378. doi: 10.3389/fncel.2019.00378. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31507378 Free PMC article. No abstract available.
-
Formononetin: A Pathway to Protect Neurons.Front Integr Neurosci. 2022 Jul 13;16:908378. doi: 10.3389/fnint.2022.908378. eCollection 2022. Front Integr Neurosci. 2022. PMID: 35910340 Free PMC article. Review.
-
Decreased Hippocampal Neuroplasticity and Behavioral Impairment in an Animal Model of Inhalant Abuse.Front Neurosci. 2018 Feb 6;12:35. doi: 10.3389/fnins.2018.00035. eCollection 2018. Front Neurosci. 2018. PMID: 29472835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical